Centrus Energy Corp. (LEU) Earnings Call Transcript
August 6, 2026
Earnings Call Speaker Segments
Good morning, everyone, and welcome. We appreciate all of you joining the call, and also those of you tuning in through the webcast. On today's call, we'll be going over our results for the second quarter of 2026, which closed on June 30th. Joining us today are Amir Vexler, our President and Chief Executive Officer, and Todd Tinelli, Senior Vice President, Chief Financial Officer, and Treasurer. This call comes after the earnings news release we put out yesterday, and earlier today we filed a Form 10-Q report for the second quarter. You can find all of our news releases and SEC filings, which include our 10-K, 10-Qs, and 8-Ks, on our website. A replay of today's call will be posted later this morning on the Centrus website as well. I want to remind everybody that some of what we discuss today could be considered forward-looking information involving risks and uncertainty, including assumptions regarding Centrus's future performance. Our actual results could differ materially from what our forward-looking statements indicate. You can find additional information about factors that could cause actual results to differ materially from those in our forward-looking statements in our SEC filings, including our annual report on Form 10-K and our quarterly reports on Form 10-Q. The forward-looking information we're providing today is time sensitive and accurate only as of today, August 6th, 2026, unless otherwise noted. Please keep in mind that we report results using non-GAAP financial measures, which we believe give investors additional understanding of the company's financial performance, as well as its strategic financial planning, analysis, and period-to-period comparability. A reconciliation to the most directly comparable GAAP measurements appears in the financial results section of our earnings release; this call is the property of Centrus Energy. Any transcription, redistribution, retransmission, or rebroadcast of the call in any form without the express written consent of Centrus is strictly prohibited. Thank you for your participation, and I'll now turn the call over to Amir. Amir?
Thanks, Neal, and good day to everybody joining us. For Q2 of 2026, we posted robust operational and financial outcomes, lifted by favorable momentum throughout each of our key addressable markets — commercial LEU that's already established and expanding, national security, plus HALEU. These trends keep highlighting the widening mismatch between enrichment supply and demand for uranium, which shows up in the ongoing rise of published LEU prices. With the DOE enrichment award now signed, we've unlocked considerable funding that isn't dilutive or debt-based to push forward our commercial centrifuge construction effort. That money lowers the risk on our build-out and moves us closer to first-of-a-kind costs, all while generating significant employment opportunities nationwide. Let me begin with the demand side of the equation, where we're seeing powerful tailwinds in our core market. That's worldwide commercial LEU supporting baseline electricity expansion for existing, proven Gen II and Gen III reactor designs. Here in the U.S., the NRC lately put forward several regulatory adjustments and amendments that could further spur industry growth. Should they be finalized, such changes might speed up new nuclear capacity reaching operation while cutting development expenses for operators. On top of that, the just-announced American Nuclear Supply Chain Loans program aims to assist in financing and speeding up deployment of new large-scale nuclear reactors throughout the United States. At the same time, power operators and restarts of current nuclear sites keep bringing additional nuclear energy online, which drives more LEU demand. International LEU needs are also poised to rise in several regions; in Europe, Sweden and the Netherlands are concentrating on enabling new nuclear projects, whereas Belgium is examining options to restart reactors that had been shut down. Over in Asia, growth is appearing in numerous places; take April, when TEPCO returned the 1,300-megawatt Kashiwazaki reactor to service. Shifting to the government market, we keep observing escalating demand signals for enriched uranium among multiple departments as agencies look for ways to incorporate nuclear power into their generation strategies. On the national security front, we remain engaged with the NNSA regarding its plan to sole source specific enrichment work from Centrus. Keep in mind that Centrus holds the sole viable, production-ready technology capable of satisfying national security requirements. Taken together, these point to solid indications of possible expansion in both the scale and length of the government market. Simultaneously, we're noticing growth signals in the HALEU space, where three out of four reactor designs achieving criticality before DOE's 4th of July deadline run on HALEU. We further think possible Department of War funding might assist in shortening their timelines. As a reminder, HALEU offers Centrus an incremental growth chance and serves as a possible source of near-term capital via prepayments. Since a centrifuge can serve multiple functions, whatever funding comes in — for LEU, national security, or HALEU — moves Centrus past first-of-a-kind costs. Now let's turn to our financial results for the quarter. For many of you, it's clear that our business tends to swing considerably from one quarter to the next. Because of that, we view the full-year figures as a better gauge of how our LEU and CTS operations are advancing. During Q2, revenue came in at $176.1 million, with gross profit reaching $49.9 million. Operating income was $10.4 million, net income totaled $16.8 million, and diluted earnings per share stood at $0.77. On an adjusted basis, net income was $38.7 million, while adjusted diluted earnings per share came to $1.77. Now, looking at our commercial backlog, the demand signals I mentioned previously are beginning to translate into solid order momentum, and combined with the progress we're making on build-out, our backlog has climbed to $4.5 billion, stretching out through 2040. Breaking that down, $3.7 billion sits in our LEU segment, while $0.8 billion belongs to our Technical Solutions segment. Within the LEU segment backlog, $0.7 billion comes from broker-dealer backlog, and $3 billion stems from contingent LEU and HALEU enrichment sales. Todd will walk you through our results in greater depth. On the operational side, we've achieved substantial progress over the course of the quarter, staying dedicated to rebuilding America's capacity to enrich uranium at scale. That includes finalizing our U.S. Department of Energy task order worth $900 million, which we secured earlier this year. This award will help drive deployment of large-scale production capacity as part of our multi-billion dollar LEU and HALEU capacity expansion. It represents yet another major milestone in our expansion, as we shift away from a technology demonstration contract toward a bigger contract that backs commercial-scale production. We're proud that every HALEU production requirement under our current demonstration contract with the DOE was finished two weeks ahead of schedule. Since launching our HALEU Operations contract, we've contractually produced close to two metric tons of HALEU UF6 for the government. The first new capacity from this transition should come online by 2029, but in the meantime, we're collaborating with the DOE on arrangements that would let the company privately run the existing 16 centrifuge HALEU cascade on a commercial basis. Thanks to the task order funds, plus cash from our existing broker business and a robust cash balance, we've now satisfied the financing contingency for our more than $3 billion in customer contracts covering LEU and HALEU purchases — another critical milestone that de-risks and pushes forward our ongoing multi-billion dollar expansion. One more notable accomplishment for Centrus this quarter was signing a letter of intent with Oklo for Centrus to provide HALEU to power as many as five Aurora powerhouses over multiple years beginning in 2029. We're now securing and locking in HALEU fuel commitments from off-takers, and just recently, we announced an off-take contract for HALEU with X-energy. That represents a key step toward guaranteeing dependable HALEU supply for next-generation reactors and confirms our first-mover advantage in the HALEU market. Typically, our HALEU off-take commitments involve prepayments made to Centrus, and those terms will get hammered out further in a definitive agreement down the road; such prepayments represent yet another avenue of non-dilutive, non-debt funding for our expansion, and it's a structure we plan to use in upcoming HALEU off-take contracts. Progress also keeps happening with our supply chain partners, and that includes securing sizable commitments that help shield us from price swings and keep costs steady. Contracts are now finalized with roughly 75% of the suppliers we've flagged as critical. Beyond that, we keep assessing M&A opportunities within our supply chain that fit our long-term growth strategy and deliver value to shareholders. During the second quarter, we achieved significant strides in adding workers at both Piketon and Oak Ridge. Lastly, it's a point of pride that Centrus received an invitation in July to join the S&P SmallCap 600 Index, a reflection of the part we play in boosting U.S. energy security and reinforcing America's nuclear fuel supply chain. Shifting to guidance; our 2026 annual guidance for total company revenue of $450 million-$500 million is being reaffirmed. Capital spend overall falling between $350 million-$500 million. Completing contracts with 100% of the partners we consider critical. Issuing a certified for construction package. A minimum of 100 net new employees brought on at our Oak Ridge facility. At the same time, because of the progress made this quarter, our 2026 annual guidance for Piketon workforce additions is being raised from over 100 net new employees to over 175 net new employees. And finally, we're thrilled to share that our first centrifuge at the Oak Ridge facility is slated for completion at some point in 2026, a major achievement and milestone showing that our supply chain has coalesced. I'll hand the call over to Todd now and come back with a few closing thoughts and remarks. Todd?
Thanks, Amir, and good morning, everybody joining today's call. I'd like to take you through what we reported. The numbers came in right where we had internally expected, and they showed both the usual sequential change in contractual mix from one quarter to the next and the start of spending on our manufacturing program. As I mentioned, I'll present the financials both for the quarter and on a trailing 12-month basis. Second quarter total revenue reached $176.1 million, which is up $21.6 million, or 14%, from the same period a year ago. TTM revenue came to $473.9 million. Our LEU Segment brought in $153.4 million during the second quarter, a 22% gain over the prior-year period. SWU revenue for the quarter fell by $25.7 million, the result of a 23% drop in the volume of SWU sold, partly offset by a 3% rise in the average SWU selling price. Centrus also recorded $53.4 million in uranium sales during Q2. The Technical Solutions Segment posted second quarter revenue of $22.7 million, down $6.1 million, or 21%, from the prior period, mainly because revenue from the HALEU Operation Contract declined by $5.9 million. Centrus earned gross profit of $49.9 million in the second quarter and $112.1 million on a TTM basis, versus gross profit of $53.9 million in Q2 2025. The LEU Segment's second quarter cost of sales was $101.8 million, up 36%, or $26.8 million, year-over-year, on the strength of higher uranium sales in Q2 2026. Uranium costs rose because more uranium was sold. SWU costs dropped 23% on lower SWU volumes, partly offset by a 13% rise in the average cost of SWU sold compared with Q2 2025. Technical Solutions cost of sales was $24.4 million, a decline of $1.2 million, or 5%, from Q2 2025, mostly tied to the HALEU Operations contract. The company produced net income of $16.8 million and adjusted net income of $38.7 million in the second quarter, against net income of $28.9 million and adjusted net income of $34.5 million, respectively, in Q2 2025. On a fully diluted basis, that works out to second quarter 2026 earnings per share of $0.77 per unit and adjusted earnings per share of $1.77, respectively, versus $1.59 and $1.90, respectively, for Q2 2025; over the trailing 12 months, Centrus produced net income of $48.5 million and adjusted net income of $92 million, respectively. The drop in second quarter net income was mostly due to a $12.8 million rise in SG&A costs, which came from higher stock compensation cost, along with a $7.5 million increase in advanced technology costs in Q2 2026. Partly offsetting that was an $8.3 million gain in investment net income for Q2 2026. Second quarter adjusted net income takes in $10.6 million of growth expenses within our advanced technology cost and $17.7 million of stock compensation costs, which together, after tax adjustment, equal $21.9 million. The advanced technology cost line covers short-term expenses we can't capitalize, tied to growing operations at Piketon and Oak Ridge, since they relate to manufacture readiness and security training before the build-out. For a reconciliation of net income and adjusted net income, see the financial results section of the earnings release we issued yesterday. Looking ahead, we still anticipate a certain level of these expenses flowing through our income statement as pre-preparations carry on. At the close of the second quarter, Centrus backlog across both segments reached $4.5 billion and stretches to 2040. That growth came mostly from a roughly $600 million rise in LEU and HALEU enrichment sales within the LEU segment. Within the segment's enrichment backlog of about $3 billion, definitive agreements account for $2.4 billion. Now to capitalization and capital spend — as a reminder, non-CapEx relates to costs and investments like prepayments to suppliers or growth costs tied to manufacture and pre-preparations. Total capital spend in the second quarter was $82.2 million, consisting of $71.6 million in CapEx and $10.6 million classified as non-CapEx, which was made up of the advanced technology cost mentioned earlier. Looking forward, we still expect the pace of both CapEx and non-CapEx spending to pick up as the year goes on. We closed the second quarter with $1.9 billion in unrestricted cash, having used our ATM opportunistically to bring in just $53.9 million. Importantly, every financial contingency in our contingent LEU enrichment backlog has now been cleared. We remain confident in our existing cash balance and believe we have sufficient funding for our near-term capital requirements. As Amir mentioned, progress so far has let us lift our 2026 annual guidance for workforce additions in Piketon, Ohio, to 175+, from 100+. At the same time, we are reaffirming the remainder of our financial and operational guidance for FY 2026. Lastly, we're excited to report that our first centrifuge is expected to be finished in Oak Ridge in 2026 — a key milestone in our build-out. With that, I'll hand the call back to Amir. Amir?
Thanks, Todd. I feel good about the significant strides we took in Q2 throughout our operations and with our strategic partners. To sum up, robust demand indicators are showing up in each of our three addressable markets: commercial LEU, national security, and HALEU. That heightened demand, combined with what we have achieved in our centrifuge manufacturing program, has produced greater momentum in our order book backlog. Notably, the robust demand indicators in commercial LEU have created a very favorable pricing landscape. Long-term LEU pricing kept climbing steadily so far this year, while spot pricing is still at the high point established last year. With market tightness expected for at least the near and mid-term because supply is constrained while demand keeps expanding, Centrus is positioned well to gain as a demonstrated enricher. Going forward, we will stay focused on our mission of rebuilding America's nuclear fuel supply chain and are heartened by the ongoing strong trends in the wider macro environment that are driving global nuclear power development. Lastly, we are thrilled to hold our first Investor Day in December at our American Centrifuge plant in Piketon, Ohio. We are eager to share more regarding our strategy, growth opportunities, and long-term outlook at that event. With that, I will hand the call to the operator for questions. Operator?
Hi there, David Choe here, filling in for Jon Windham. Nice work on everything you accomplished during this quarter. I appreciate you fielding my question. Very briefly regarding the X-energy partnership, might you provide some clarity on the timing of any shipments you anticipate making? From what I understand, X-energy intends to launch their initial plant around the first half of 2028. Would you anticipate that any portion of those quantities would originate from the demonstration cascade that you are transitioning into commercial offtake? Thanks.
Yes. Hello. Good morning. Excellent questions. Many thanks. Let's begin with what you asked about X-energy. As you noted, we shared news of a highly promising arrangement earlier today. Broadly speaking, I would frame this as further strong proof and yet another data point demonstrating that Centrus is rapidly emerging as a pioneer and the preferred choice for HALEU. We take pride in being able to back some of the fresh advancement when it comes to advanced reactors. As you're aware, we already possess a robust order book for LEU too. I want to point out that the additional thrilling aspect here is that these HALEU contracts also involve a prepayment, which benefits us considerably; now, regarding what you specifically asked, regrettably, I'm unable to share excessive specifics concerning deliveries and other particular terms within the contract; providing those isn't possible for us. Like I mentioned, on the whole, simply as a broad remark, it's thrilling, it's definitive, and that matters greatly; we eagerly anticipate completing it.
Thanks. I'll hand it over to the next person.
Morning, Amir, and to everyone else — appreciate the background you've shared up to now. Since we're under a year and a half away from the Russian import ban taking effect, I'm wondering whether buyer behavior has shifted at all. How should we frame possible financial impacts, things like inventory or working capital, if customers decide they'd rather buy ahead of time? Once more, this all presumes no additional waivers get granted, but I'd just like to get a feel for whether they're ready to commit at today's market level for SWU, or if you're noticing any shift at all in how customers are acting.
Hey, good morning, Bill. Appreciate the question. Since you've given me latitude to respond however I like, let me share some broad observations about what we're witnessing — though I likely can't go deep into specifics regarding the conversations we're holding with customers. You might recall me mentioning this previously: we anticipate supply-side tightness as we approach the end of the decade. My sense is that some of it is beginning to show. Customer interest is carrying strong momentum, broadly when it comes to purchasing SWUs, and more specifically when it comes to choosing Centrus as the newcomer and fresh participant in this market. Order momentum is quite strong, and as I noted during the earnings call, LEU pricing has climbed considerably up to now, which benefits our business greatly and further strengthens the investment we're getting ready to make here. Taken together, I'd say this matches prior conversations we've had about the direction we expect the market to take. With demand-side additions to the equation and very little added on the supply side — at least not within the coming year or two — that momentum is working in the sellers' favor.
Thank you, sir.
Hello, good morning. Luke here, filling in for Eric. We appreciate you taking our question. Regarding the cost savings side, clearly the Palantir partnership is already demonstrating tremendous value. But could you provide some sense of how the outlook for additional cost savings may shape up over the duration of your expansion project, in terms of a magnitude comparable to what you have managed to accomplish so far, given that you are still only at the early phases, and whether there are any specific cost categories you are currently prioritizing? Thank you.
Good morning, and once more, thank you for asking that. You are in fact highlighting something that sits at the very top of our priority list as we kick off the project, as we begin manufacturing, as we start making commitments to commercial deliveries and to delivering our centrifuges. It matters enormously, as I said during the past couple of earnings calls, and I will say it again now, that we simultaneously unlock efficiencies, cost savings, and cost reduction efforts. We spoke briefly about our work alongside Palantir, together with some of our EPC partners; we have numerous supply chain initiatives designed to produce precisely what we are discussing here. The ability to secure bigger order books, the fact that we now possess greater visibility into the customer base regarding ordering, enables us to conduct more leveraged purchases and achieve savings on the supply side of our construction. Another point I will bring up is that, beyond leveraging and anticipating supplier savings, we are simultaneously kicking off many internal initiatives to make certain that the manufacturing facilities we are establishing and the processes we are establishing incorporate things such as lean and things that are used to maximize efficiencies. All of this will lead, without question, to cost savings. As for providing you specifics on what that amounts to numerically and what our targets are, that is not something I would discuss on this phone call. I will say again that the ability to secure long-term agreements and large orders because of some of the visibility I mentioned produces meaningful cost savings for us.
Got it. Appreciate that.
Hi, everyone. Congratulations once more on the supply deals with Oklo and X-energy.
Wonderful. Thanks so much.
I realize there's a cap on what you're able to share, but perhaps a side-by-side might give us some useful perspective. Regarding those 2 HALEU deals that were just signed with Oklo and X-energy today, could you point out any areas where they align or diverge? Perhaps on scope, schedule, or how milestones are set up? Is either one more advanced or more locked in? Do either include take-or-pay obligations?
Yes. As you're aware, there's a fairly tight limit on the specifics I can go into, simply because NDAs are in place, and revealing particulars of commercial agreements isn't something we normally do. That said, many things overlap. On the past few calls I've noted that we're beginning to witness a far stronger capacity among our customers to make legally binding commitments — a definitive agreement — and that's exactly what the X-energy deal we announced reflects, and it's also the direction we're heading with Oklo. I'd like to clarify a bit about how an LOI works compared with a contract. An LOI comes before a definitive contract. It represents agreement on the broad terms as we understand them, and after reaching that stage, we're quite near to locking down contractual terms and conditions. The overlap we're observing is that some of these OEMs can now commit and treat fuel as a priority within their purchasing strategy. What we're witnessing is the SMR market maturing. Perhaps the key point I want to get across on this call is that we're now out in front. We are the HALEU supplier. We've become the first choice for HALEU supplies. As you know, we tend to treat HALEU as a bonus. In the market, LEU is the dependable business, the certain bet. We've been concentrating heavily on that. For us, HALEU has truly been a substantial bonus. I've spoken at length about economies of scale in general; naturally we're working not just to secure the HALEU, but also to obtain the LEU feed, which matters enormously to us for economies of scale. The third overlap we're noticing is prepayments. We're seeing the readiness, the capability, and our fairly strong inclination toward a prepayment, which contributes considerably to the non-dilutive capital we can put to work.
Thanks, Amir. Appreciate the call.
Thank you.
Hello, this is Ted sitting in for Vik. I appreciate you letting us ask a few things. I'd like to circle back to the guidance. Would you be able to walk us through what's behind those two ends of the range? In the release, there was a mention of possible roll-off of funding related to the operations contract. I'm just trying to figure out where that lands inside the revenue guidance range.
Yeah. As a quick reminder, we raised our revenue guidance during the prior quarter. Something I'd ask you to keep in mind is that our business does fluctuate from one quarter to the next, so that's always a smart approach. That's the reason we discuss our earnings on a trailing 12 month basis too; quarter-over-quarter guidance isn't something we're giving, but for the year we are holding our guidance steady. Given our solid order book and the market continuing to mature, we believe we can keep our guidance where it stands right now for revenue as well as CapEx. On top of that, one more positive development is that we've added to our headcount at the Piketon facility, which reflects ongoing momentum and the build-out we're doing at Piketon.
Let me build on Todd's remarks. There's a very exciting piece of news we're sharing and putting out here: the initial centrifuge will be finished at an Oak Ridge site at some point in 2026, which is what we announced. Once again, that matches up with the money we're putting in and the project planning we've got in place. This likely counts as one of the most thrilling milestones on the path to making enrichment at Piketon a reality and getting it started.
Understood, thanks. I have one more thing to ask about — regarding how much the backlog went up from one quarter to the next, could you explain what drove that growth? Did getting the DOE awards signed play a part, or do some of the newer awards sit inside it? And how exactly is backlog defined on your end? Is it inclusive of any LOIs?
Sadly, I'm not in a position to share a great deal of specifics, though I can say the DOE is not part of this; everything here is commercial agreements. What pushed the backlog higher relates to commercial agreements. Beyond that, there's really nothing more I can say.
Thanks.
Morning. Nice work on all the strong momentum. I'd like to dig a bit deeper into the offtake agreements, perhaps at a high level. How do you think about the share of your future capacity that you want covered by signed offtake agreements? This is, I believe, a HALEU specific question, but what portion of capacity do you want offtake agreements signed for?
Yes. Morning. Thanks for asking. A few calls ago, I believe, I noted that our strategy really hinges on how our solid order book looks, and that would essentially set the mix of LEU versus HALEU that we build. Right now, given what we're locking in, we aren't really altering the proportions of what we're building out. Both are going to get built. We have the flexibility to build both. It depends on the customers who step forward and make firm commitments — that's what we'll build. Obviously, we'll be seeking solid commitments for the longest term contract we can get. We communicated precisely those points to the market last year, and I'm glad to say it's been progressing just as we communicated it last year as well.
All right. Thanks. I'll hand it over.
Hi, everyone. Appreciate you taking my question. Perhaps this builds on what you're doing with Palantir and on efficiencies generally. In one of your earlier answers you touched on cost-side efforts — could you share more about the progress you aim to achieve when it comes to shortening lead time?
Hi, good morning, Ryan. Thanks for asking. That's right. In my view, lead time matters enormously, both as an opportunity and in terms of taking out cost. Why? Because we're working backward from commercial agreements, and honestly, those agreements call for timelines that are even quicker. As I told someone in an earlier question, supply has a gap in the market. Whoever brings enrichment capacity to market at the earliest possible point genuinely earns a real, tangible payoff. Some of what we're doing with Palantir, some of what we're doing alongside our EPC providers and other partners — that is, the big suppliers I mentioned before — with all these essential suppliers, we've got continuing work and various projects that we launched in which we examine lead times and we examine taking out cost, since shorter lead times truly convert into greater revenue and the ability to capture revenue far earlier, far sooner. That's where our attention is. I hope that answers your question with enough detail. I doubt I can offer anything more specific than what I've said.
No, that works well. Thanks for that, Amir.
Hello, good morning to you, Amir and Todd. I'd like to steer things back toward the guidance as well. When we consider how CapEx ramps up over the second half of the year, along with the centrifuge being finished, what's the right way to think about how the remaining spending is paced between now and year-end? And then, looking ahead into 2027, how does that CapEx figure ultimately shake out?
Appreciate that, Nick. So, the first thing I'd note is that this project is going to keep ramping. At this stage, we won't give guidance for anything past 2026. Like I said, you can see we held our 2026 guidance steady on CapEx. You watched the latest quarter, where our spending came through prepayments, capitalized labor, or pre-orders. This project is going to keep advancing. Another thing I'd highlight that demonstrates further momentum would be the higher headcount over at Piketon. Our view is that this faster spending and pushing our project ahead, combined with growing customer demand and backlog, let us proceed at a pace that satisfies what our customers need for their future-period deliveries.
Amir here, Nick. There's a point I'd like to tack onto Todd's remarks. It might drift a bit from your question about cadence, yet I raised it before and want to stress it once more: we made an announcement — and it thrills us — that the initial centrifuge will be finished during this year. The aim, clearly, sits right here: we're putting up a production plant, the first such facility anywhere in America, built to turn out one of the most intricate devices humankind has ever created — the centrifuge. This plant is remarkable. Brilliant staff, brilliant engineers, brilliant vendors are all engaged on it, and we take delight in the reality that we're accomplishing a feat nobody has ever achieved previously. Things are falling into place. That earliest centrifuge stands as the initial tangible indicator and evidence of this. Plainly, the plan calls for a production rhythm completely aligned with the way we're meant to supply the product beyond the close of this decade. Naturally I can't hand you guidance on figures, as Todd noted, but you should certainly view it in that light.
Excellent; that's useful. I'm eager to see it come December. Thanks.
Hello there, good morning, everyone. Perhaps continuing from the previous subject, regarding recruitment, you're clearly still achieving encouraging momentum when it comes to speeding up the staffing targets at Piketon. Could you discuss the possibility, I suppose, of lowering the risk or bringing forward the schedule to the initial cascade, considering how hiring has sped up? Do those things relate to each other at all, or might you address any additional advantages for the business or the schedule stemming from faster hiring? Thanks.
Yes. This sort of connects to the question from before, perhaps two or three back, when I mentioned not just savings on cost but shortening lead times. Having the ability to shorten lead times provides concrete, genuine value to the company regarding how quickly we can reach the market. Many of our initiatives involve moving faster and removing expenses. A portion of that quicker expansion of the staff you mentioned, and as discussed within our guidance, ties directly to that. On the whole, I see that as a favorable indicator. I see that as something intended to firmly guarantee we fulfill our commercial obligations and possibly exceed them. Clearly, there's nothing fresh to report right now.
Alright, let me add just one further observation. When you consider the staffing numbers at Piketon compared with Oak Ridge, as Amir mentioned, what we're building is essentially the first facility of its kind anywhere in the United States for producing enriched uranium. The centrifuges themselves get built at that location, and from there they're transported so they can be put in place and brought online at Piketon. Everything here ties together — the supply chain, the lead times — because the faster we can get that manufacturing operation up and running and get those centrifuges built, the faster they can be sent down to Piketon. Right now, quite a bit of activity is underway at Piketon getting things ready so those centrifuges can arrive and be installed, which lets us start the enrichment process. I'm hoping a good number of you will be able to come to the investor day this December, where you'll get a chance to actually view the facility and gain a much deeper understanding of it.
I value the information, and I'm eager for what's coming. Thanks, everyone.
Hi, Amir, and hello to the whole group. We appreciate you fielding questions from all of us. Many of the things I wanted to ask have already come up, but I'm just trying to tie together what you all just shared. Do we still expect that commercial output will begin at some point near the end of 2029 at Piketon? Or could that schedule possibly shift earlier?
I'd drop the word "late" and simply state 2029. That is definitely what we're aiming for. To borrow your phrasing, to tie it together, we're looking into possibilities and putting in serious effort so that we might be able to shorten the timelines. As of now there's nothing to share and no promises have been made.
All right. That helps, just to recap. Appreciate it. I'll pass it along.
Hi, Amir. Thanks for fielding my questions. Could you discuss what's happening with SWU pricing? I believe, if I caught it correctly, prices rose 3% in the quarter, while costs climbed 30%. What's driving that increase in costs?
Hi, good morning, Sameer. This ranks among my favorite topics to address. The reason is it genuinely encapsulates the market in a single figure that anyone can examine. Naturally, views might vary, but it boils down to fundamental economics. SWU prices have been rising and continue to rise because demand exceeds supply. Even more significantly, it's 2026, and we still have roughly two, three more years until capacity begins to come online from many announced projects. My own perspective remains that constraints will persist. We'll keep witnessing these seller's market type dynamics, if you will. Put simply, no new capacity has been introduced. Every single day brings news of additional new reactors, operating ones, decommissioned reactors restarting, fresh proposals for new reactors. Every one of those needs fuel. Every one of those needs more fuel than was needed previously. Capacity hasn't changed. That's what the prices reflect. As I mentioned, over the short term, I don't expect that situation to shift dramatically.
Amir, could you also weigh in on the factors pushing expenses higher at the same time? My guess is that energy is the main driver, though a few additional cost items are plainly climbing too.
Sure — what we're seeing is a combination involving both our SWU and uranium expenses. Naturally, we aren't able to speak to the particular cost tied to any individual deal, since inventory cost reflects a contractual blend in the way we record that inventory on the books. Once more, SWU prices are holding up well. Our margins are arriving right where we expected them to, and we keep observing market demand that should keep those SWU prices supported.
Got it. Appreciate the answer. I'll pull back.
Hello, and good morning. Thanks for letting me ask. Could you discuss the way pricing is set up within the offtake contracts you're currently going after? Do you rely on fixed-price arrangements, or do you tie things to some form of pricing index? And if it seems like the market is getting tighter, what volume of offtake would you aim to lock in at this point?
Yeah. Right now, we're not in a position to discuss our pricing. My guess is that your question relates to pricing across all offtake deals. I simply want to confirm I've got your question right, Drew.
Yeah.
All right. Yeah. Sadly, we're unable to discuss what our contracts are priced at specifically. NDAs prevent that. One thing that stands out as really significant — and Amir brought it up multiple times on this call, I believe — is that these contracts are new, plus we satisfied the financial contingencies tied to our backlog, meaning they are definitive. Clearly, the first-of-a-kind cost, in what we'd describe as our initial build-out, is now behind us. Consequently, signing more offtake brings about greater economies of scale, and we keep fulfilling every demand from our customers. The HALEU market, as you can observe, has developed rather well across the past six months, and we remain present as the market's first HALEU provider.
All right, that's great. Thanks a lot.
Hey there, everyone. Appreciate all the detail you provided, and congratulations on the headway being made, whether it's in Piketon or Tennessee, and with a number of these customers. Perhaps you could fill us in on where things stand regarding talks with utilities about LEU and possible long-term agreements, now that the financial contingencies have been satisfied. What's the right way to view the pace of additional orders from here through 2029? It's encouraging to see certain SMR developers that rely on HALEU taking initiative, but I'm wondering whether you have a feeling or a goal for the visibility we can keep building from now until 2029. And are you noticing greater urgency around contracting among some of the more conventional utility buyers too, in light of where pricing is heading?
That's a wonderful question. I appreciate it. I've mentioned on prior calls many times that the LEU market was something we cared about deeply and devoted a great deal of attention to. It gives us a robust base for our offtake backlog; these represent firm commitments that operating reactors require daily and will keep requiring for many decades. Clearly, they sit at the very top of our priorities. The situation there is, as you accurately noted, that we essentially no longer have any contingency requirement left, since we've crossed that threshold. As a result, we're seen as a far less risky startup and a far less risky enricher in the marketplace. My expectation is that this will hand us considerably more leverage with utilities. Broadly speaking, we're observing heightened interest and a more inward-looking stance from utilities toward the small number of enrichment suppliers currently active in the market. I get the sense that considerable attention is being paid to the new entrant, to ensure competition exists in the market. Being the new entrant and the party making that investment brings us many advantages, and we now present a far lower risk profile than would have been the case, say, several years back. On the whole, things are developing in a way that benefits us, and we remain in ongoing dialogue with utilities seeking to meet their LEU requirements for many years ahead. I'd also note, as I've said previously, that a number of these conversations don't produce the kind of linear figures you can monitor on a quarterly basis; the way they come together is uneven. Certain conversations take more time, others take less. On the whole, we keep treating this as a commercial priority — the reactors already in operation and the LEU demand that exists today within the U.S. and internationally.
All right. To build on that a bit, when it comes to the timing of contracts — I get that certain things won't necessarily show up in the interim — are 2028 and 2029 sort of the big target dates for locking some of those in? Might we see any of that sooner?
Sure. Let me make sure I've got your question right. What you're asking is whether there's a chance to deliver in 2028, meaning sooner than what we've announced?
No. When it comes to contracts over a longer horizon, are they somewhat waiting to observe how things develop regarding additional items past the backlog you have right now? And is there meaningful potential for that backlog to grow from today through 2029?
Correct. Yes. I trust that addresses what you asked. Should that not be the case, kindly redirect me. How utilities purchase differs greatly from one utility to the next. Bigger utilities, along with the smaller ones, each have distinct approaches regarding the timing of their market entry. Certain ones possess varying degrees of comfort with risk, or varying levels of enthusiasm for established players as opposed to newcomers. Like I mentioned, given that we currently are shipping centrifuges—or we will soon show that we are shipping, setting up—and additionally we carry zero financial contingencies, my belief is that significantly more interest will come from utilities currently in a wait and see posture, and a good number of them fall into that category. I absolutely anticipate that.
Yes. One more point I would make is that, clearly, the Russian ban was expected by the market, and in the short run a great deal of the market—utilities—has locked in where it stands. Talks with those utilities, along with the RFPs, concern later periods, and those later periods are when we intend to bring capacity online. Let me simply note that a robust broker business exists on our side, one that has bolstered Centrus' cash flows across prior years and keeps bolstering Centrus cash flows, and we are prepared to fulfill whatever customer requests arrive in the short run.
Understood. That's genuinely useful. Many thanks.
Hello, everyone; Peyton here, filling in for Joe. We appreciate you fielding our questions. Taking a broader view beyond this quarter, I suppose. As the HALEU cascade shifts away from DOE cost-reimbursable work toward commercial operation, how would the fully ramped earnings power of the combined LEU and HALEU business appear? And it would be wonderful if you could share a few points on what must go right during the coming 18 to 24 months to reach that point. Thanks.
Yes; no further guidance is offered by us on that. Clearly, moving the demo cascades into commercial service shows our capacity to run these cascades, our capacity to make HALEU that is available in the marketplace. We're thrilled to keep those cascades going and supply commercial HALEU. Clearly, a LEU feedstock is needed for these; this will build out over time. No extra guidance on this can be given by us at present.
Yes, I want to tack on a point to Todd's remarks, even if it doesn't tie straight into what you asked. Like he mentioned, the guidance we're able to give on this is quite restricted. If you consider what the demo cascade was meant to accomplish, the goal was genuinely to showcase our technology and take the risk out of it. What a fantastic narrative, moving that demo cascade equipment straight into commercial operations. There's plenty to be drawn and inferred from this regarding how our technology performs, what it's capable of, and the lofty bar we've set for it out in the field. Taken together, we view this as really encouraging headway and growth.
Excellent. Thanks, everyone.
Appreciate it, operator. That brings us to the end of our investor call covering the second quarter of 2026. As we always do, I'd like to say thanks to those listening in, to our analysts joining online, and to everyone who dialed in. We can't wait to talk with all of you again when the next quarter comes around, and to pass along additional details about our investor day that's coming up.
Thanks. That brings today's conference call to a close, everyone. We appreciate you joining us. You're free to disconnect at this point.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Centrus Energy Corp. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Centrus Energy Corp. earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.